-ProLabel fusion construct (fxn-ProLabel) and analyzed by WB with antifrataxin and anti-tubulin antibody. Pre: precursor; int: intermediate; mat: mature frataxin forms expressed by the fxn-ProLabel construct; end mat: endogenous mature. The asterisks (*) denote non-specific bands. B) Plate layout of Human ON-TARGETplus ubiquitin conjugation siRNA library (Dharmacon). Validated individual control siRNAs and pools are pre-dispensed into column 1 of each RTF library plate, providing a consistent baseline for screening and assay efficiency. Cells were transfected with Alexa Fluor siRNA in the indicated wells to control transfection efficiency. A column of no-siRNA transfected cells was included in each plate and cells treated with the proteasome inhibitor MG132 were included as positive control (column 12). C) Representative results obtained in one of the screening plate. The graph shows the results obtained from the luminometer reading of one of the plates used for the screening. Each dot represents the RLU (Relative Luminescence Unit) measured in each individual well, corresponding to a determined siRNA pool. The red line indicates the arbitrary threshold that was set as the median of the luminescence measured in all the wells of the plate plus three median absolute deviations. Red dots highlight siRNA pools that were considered positive in this plate. Six replicates per plate were analyzed. siRNA pools that scored above the threshold in at least 4 out of 6 replicates were selected for further validation. D) Table illustrating the primary hits identified from the siRNA screening. NMD: number of median deviations above the plate median (NMD > 3 was considered a hit on any single replicate). FI: fold increase over plate median (before normalization). 
